Analyst Rating Update on Imperva (IMPV)

Imperva (NYSE:IMPV) : The consensus on Imperva (NYSE:IMPV) based on 16 analyst recommendation on the company stock is 1.5, which is interpreted as a Strong Buy recommendation. Zacks Investment Research has issued a rank of 3 which endorses a Hold on the stock. However, 11 brokers have a differing view as they consider the stock to be a Strong Buy at current levels. 2 analyst believes that the stock is a Buy, which can produce decent returns in the future. 3 experts consider that the stocks earnings and the quoted price is in harmony, hence, they give it a Hold rating.

Imperva (NYSE:IMPV) : Currently there are 15 street experts covering Imperva (NYSE:IMPV) stock. The most bullish and bearish price target for the stock is $85 and $36 respectively for the short term. The average price target of all the analysts comes to $64. The estimated standard deviation from the target is $13.69.

For the current week, the company shares have a recommendation consensus of Buy. Also, Needham downgrades its view on Imperva (NYSE:IMPV) according to the research report released by the firm to its investors. The shares have now been rated Hold by the stock experts at the ratings house. Earlier, the shares had a rating of Buy. The rating by the firm was issued on May 6, 2016.

Imperva (NYSE:IMPV): stock turned positive on Tuesday. Though the stock opened at $41.25, the bulls momentum made the stock top out at $43.39 level for the day. The stock recorded a low of $41.17 and closed the trading day at $41.95, in the green by 2.84%. The total traded volume for the day was 986,754. The stock had closed at $40.79 in the previous days trading.

In an insider trading activity,The officer (Chief Financial Officer) of Imperva Inc, Schmid Terrence J. sold 5,000 shares at $37.66 on May 31, 2016. The Insider selling transaction had a total value worth of $188,300. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.

Imperva, Inc. provides cyber-security solutions that protect business-critical data and applications. The Companys suite of cyber-security offerings enables organizations to discover data and application assets and vulnerabilities, to protect information. Its Imperva SecureSphere platform provides database, file and Web application security across various physical and virtual systems in data centers. Its Imperva Incapsula product line provides cloud-based Website security, denial of service protection and performance solutions. Its Imperva Skyfence product line provides visibility into, and control over, cloud and Software-as-a-Service applications, including shadow information technology. In addition, all of its cloud offerings protect against the threats created as the enterprises shift to deploying their applications and storing their data in the cloud. Its SecureSphere product line secures business-critical applications and data from hackers and malicious insiders.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.